James Legg

James is a Chartered Patent Attorney and European Patent Attorney in the Biotechnology and Life Sciences Group.

James has experience in advising on a wide range of intellectual property and commercial matters affecting both large and small biotech and life science clients. He specialises in preparing and prosecuting UK, European and PCT patent applications, and in representing clients in European opposition and appeal proceedings. He has also advised clients involved in multi-jurisdictional patent litigation.

James has particular expertise in handling patent and technology matters relating to biological therapeutics and molecular biology, acting in matters regarding: antibody therapeutics and vaccines; diagnostic/monitoring assays e.g. assays based on antibodies, next-generation sequencing, oligonucleotide arrays and RNA in situ hybridization; genetic analysis based on e.g. DNA amplification technologies, molecular beacon probes and nucleotide quantitation; genetic engineering and gene silencing e.g. antibody engineering, CRISPR/Cas gene editing, microorganisms for biofuel production, RNAi and virus-like particle (VLP) engineering; small molecule therapeutics; and stem cell technology.

He has worked with clients from a diverse range of industries including: pharmaceuticals, biologics, biomedical, diagnostics, nutrition, and consumer goods companies.

James is also an Emergency Medical Technician (EMT) with the East of England Ambulance Service NHS Trust.

James has an MA Cantab (Natural Sciences) and a PhD in molecular biology, both from the University of Cambridge.